CLB - Core Laboratories N.V.

NYSE - NYSE Delayed Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 51.72B
Enterprise Value 32.08B
Trailing P/E 17.45
Forward P/E 117.08
PEG Ratio (5 yr expected) 13.31
Price/Sales (ttm)2.48
Price/Book (mrq)9.14
Enterprise Value/Revenue 33.00
Enterprise Value/EBITDA 617.03

Trading Information

Stock Price History

Beta (3Y Monthly) 2.16
52-Week Change 3-67.04%
S&P500 52-Week Change 3-0.33%
52 Week High 3122.11
52 Week Low 336.61
50-Day Moving Average 348.81
200-Day Moving Average 358.80

Share Statistics

Avg Vol (3 month) 3714.87k
Avg Vol (10 day) 3674.5k
Shares Outstanding 544.35M
Float 43.59M
% Held by Insiders 11.49%
% Held by Institutions 1112.78%
Shares Short (Jul 31, 2019) 43.82M
Short Ratio (Jul 31, 2019) 45.33
Short % of Float (Jul 31, 2019) 411.26%
Short % of Shares Outstanding (Jul 31, 2019) 48.61%
Shares Short (prior month Jun 28, 2019) 43.34M

Dividends & Splits

Forward Annual Dividend Rate 42.2
Forward Annual Dividend Yield 45.94%
Trailing Annual Dividend Rate 32.20
Trailing Annual Dividend Yield 35.94%
5 Year Average Dividend Yield 42.19
Payout Ratio 4108.37%
Dividend Date 3Aug 12, 2019
Ex-Dividend Date 4Jul 19, 2019
Last Split Factor (new per old) 21/2
Last Split Date 3Jul 9, 2010

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq)Jun 30, 2019


Profit Margin 14.30%
Operating Margin (ttm)14.31%

Management Effectiveness

Return on Assets (ttm)8.95%
Return on Equity (ttm)51.72%

Income Statement

Revenue (ttm)693.59M
Revenue Per Share (ttm)15.66
Quarterly Revenue Growth (yoy)-3.70%
Gross Profit (ttm)203.88M
EBITDA 122.02M
Net Income Avi to Common (ttm)90.33M
Diluted EPS (ttm)2.22
Quarterly Earnings Growth (yoy)10.80%

Balance Sheet

Total Cash (mrq)12.57M
Total Cash Per Share (mrq)0.28
Total Debt (mrq)366.81M
Total Debt/Equity (mrq)190.56
Current Ratio (mrq)1.80
Book Value Per Share (mrq)4.24

Cash Flow Statement

Operating Cash Flow (ttm)103.98M
Levered Free Cash Flow (ttm)100.95M